Terumo taps DeRyke as CV CEO | Personnel Moves – April 7, 2017

Terumo Corp. (TYO:4543) said yesterday it tapped Rob DeRyke as its new CV group prez & CEO, effective April 1, 2017, succeeding a retiring Mark Sutter. Prior to his appointment, DeRyke operated as Terumo CV group electromechanical systems division prez, the company said. “Under his leadership, Rob brought stability and improved profitability to the business,” Terumo Corp prez & CEO Shinjiro Sato said in a press release. DeRyke joined Terumo in 2012 as corporate quality VP, and has 25 years of experience in med device and pharmaceuticals, the company said. He has previously held positions at Baxter (NYSE:BAX), Hospira and Thermo Fisher (NYSE:TMO). “We have a strong foundation of talent, technologies, and systems to build on as we deliver long-term value to our customers and their patients,” DeRyke said in a prepared statement.  Medplast appoints King as CEO MedPlast said today it tapped Brain King as its new CEO and board member, effective May 1, 2017. The Tempe, Ariz.-based company said the appointment is part of a planned leadership transition, with King taking over for Harold Faig, who will continue to serve on the company’s board. “This is a transition that I have been planning with the Board for some time. I am very pleased that we have recruited a leader of Brian’s caliber to lead MedPlast forward.  His industry expertise, global operations experience and commitment to quality will be invaluable to completing the ne...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Active Implants AdvaMed Alphatec Holdings Inc. Anika Therapeutics Inc. Apollo Endosurgery Aurora Spine Baxter Biocorp Biogen Idec Biolase Technology Inc Bioventus LLC Bonesupport Clal Biotech Delcath Sys Source Type: news